Elotuzumab
Update Carfilzomib Kyprolis
(UPDATE) Ixazomib
Selinexor
(UPDATE) Daratumumab (MM)
The Leukemia and Lymphoma Society
NCCN Virtual Reimbursement Resource Room
NCCN COVID-19 Resources Page
ASCO: COVID-19 Medical Resources